Alison Hanstead represents clients in complex patent and antitrust litigations and commercial disputes, in both federal and state courts. She has significant experience with Hatch-Waxman-related litigation, and advises clients on the intellectual property and regulatory aspects of transactional matters in the pharmaceutical industry. Clients also benefit from her experience conducting due diligence investigations and drafting license agreements.
241
On December 3, 2020, the Federal Trade Commission (FTC) published its annual report on pharmaceutical patent settlements filed with the FTC under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA)—its fourth annual review since the Supreme Court’s seminal decision in (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK